Jeffrey A Cohen
Cited by
Cited by
Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria
CH Polman, SC Reingold, B Banwell, M Clanet, JA Cohen, M Filippi, ...
Annals of neurology 69 (2), 292-302, 2011
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
AJ Thompson, BL Banwell, F Barkhof, WM Carroll, T Coetzee, G Comi, ...
The Lancet Neurology 17 (2), 162-173, 2018
Defining the clinical course of multiple sclerosis: the 2013 revisions
FD Lublin, SC Reingold, JA Cohen, GR Cutter, PS Sørensen, ...
Neurology 83 (3), 278-286, 2014
Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis
JA Cohen, F Barkhof, G Comi, HP Hartung, BO Khatri, X Montalban, ...
New England Journal of Medicine 362 (5), 402-415, 2010
Copolymer 1 reduces relapse rate and improves disability in relapsing‐remitting multiple sclerosis: results of a phase III multicenter, double‐blind, placebo‐controlled trial
KP Johnson, BR Brooks, JA Cohen, CC Ford, J Goldstein, RP Lisak, ...
Neurology 45 (7), 1268-1276, 1995
Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial
JA Cohen, AJ Coles, DL Arnold, C Confavreux, EJ Fox, HP Hartung, ...
The Lancet 380 (9856), 1819-1828, 2012
Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial
AJ Coles, CL Twyman, DL Arnold, JA Cohen, C Confavreux, EJ Fox, ...
The lancet 380 (9856), 1829-1839, 2012
Differential diagnosis of suspected multiple sclerosis: a consensus approach
DH Miller, BG Weinshenker, M Filippi, BL Banwell, JA Cohen, ...
Multiple Sclerosis Journal 14 (9), 1157-1174, 2008
Experimental allergic encephalomyelitis and multiple sclerosis: lesion characterization with magnetization transfer imaging.
V Dousset, RI Grossman, KN Ramer, MD Schnall, LH Young, ...
Radiology 182 (2), 483-491, 1992
Heparin-induced thrombocytopenia: towards consensus
TE Warkentin, BH Chong, A Greinacher
Thrombosis and haemostasis 59 (01), 1-7, 1998
Extended use of glatiramer acetate (Copaxone) is well tolerated and maintains its clinical effect on multiple sclerosis relapse rate and degree of disability
KP Johnson, BR Brooks, JA Cohen, CC Ford, J Goldstein, RP Lisak, ...
Neurology 50 (3), 701-708, 1998
Evaluation of the six-minute walk in multiple sclerosis subjects and healthy controls
MD Goldman, RA Marrie, JA Cohen
Multiple Sclerosis Journal 14 (3), 383-390, 2008
The incidence and prevalence of psychiatric disorders in multiple sclerosis: a systematic review
RA Marrie, S Reingold, J Cohen, O Stuve, M Trojano, PS Sorensen, ...
Multiple Sclerosis Journal 21 (3), 305-317, 2015
A point mutation in the neu oncogene mimics ligand induction of receptor aggregation
DB Weiner, J Liu, JA Cohen, WV Williams, MI Greene
Nature 339 (6221), 230-231, 1989
Ofatumumab versus teriflunomide in multiple sclerosis
SL Hauser, A Bar-Or, JA Cohen, G Comi, J Correale, PK Coyle, AH Cross, ...
New England Journal of Medicine 383 (6), 546-557, 2020
Benefit of interferon β-1a on MSFC progression in secondary progressive MS
JA Cohen, GR Cutter, JS Fischer, AD Goodman, FR Heidenreich, ...
Neurology 59 (5), 679-687, 2002
Mechanisms of fingolimod's efficacy and adverse effects in multiple sclerosis
JA Cohen, J Chun
Annals of neurology 69 (5), 759-777, 2011
A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: overview
RA Marrie, J Cohen, O Stuve, M Trojano, PS Sørensen, S Reingold, ...
Multiple Sclerosis Journal 21 (3), 263-281, 2015
Clinical characteristics of African Americans vs Caucasian Americans with multiple sclerosis
BAC Cree, O Khan, D Bourdette, DS Goodin, JA Cohen, RA Marrie, ...
Neurology 63 (11), 2039-2045, 2004
Progressive multiple sclerosis: prospects for disease therapy, repair, and restoration of function
D Ontaneda, AJ Thompson, RJ Fox, JA Cohen
The Lancet 389 (10076), 1357-1366, 2017
The system can't perform the operation now. Try again later.
Articles 1–20